TrialThe Lancet. Oncology2013

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.

Florian Lordick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.